Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas

In recent years, targeted (biological) therapies have become available also for primary cutaneous T-cell lymphomas (PCTCLs) including anti-CD30 (brentuximab vedotin) in mycosis fungoides, primary cutaneous anaplastic large T-cell lymphoma, lymphomatoid papulosis; anti-CCR4 (mogamulizumab) in Sezary...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonego, Benedetta, Ibatici, Adalberto, Rivoli, Giulia, Angelucci, Emanuele, Sola, Simona, Massone, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670482/
https://www.ncbi.nlm.nih.gov/pubmed/37998391
http://dx.doi.org/10.3390/cells12222656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670482/
https://www.ncbi.nlm.nih.gov/pubmed/37998391
http://dx.doi.org/10.3390/cells12222656

Ejemplares similares